1. The ULK1 inhibitor ENV-201 impairs tumor growth in KRAS-driven flank xenografts as a single agent and in combination with the KRAS inhibitor adagrasib. (October 2022) Authors: Pitman, J.; Dellamary, L.; Kc, S.; de los Rios, M.; Hood, J. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗